AAAAAA
Results:
1-15
|
Results: 15
Authors:
LAPIERRE YD
JOFFE R
MCKENNA K
BLAND R
KENNEDY S
INGRAM P
REESAL R
RICKHI BG
BEAUCLAIR L
CHOUINARD G
ANNABLE L
Citation: Yd. Lapierre et al., MOCLOBEMIDE VERSUS FLUOXETINE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER IN ADULTS, Journal of psychiatry & neuroscience, 22(2), 1997, pp. 118-126
Authors:
YOUNG SN
ANNABLE L
Citation: Sn. Young et L. Annable, CCNP POSITION PAPER ON THE USE OF PLACEBOS IN PSYCHIATRY - RESPONSE, Journal of psychiatry & neuroscience, 21(5), 1996, pp. 356-359
Authors:
YOUNG SN
ANNABLE L
Citation: Sn. Young et L. Annable, THE USE OF PLACEBOS IN PSYCHIATRY - A RESPONSE TO THE DRAFT DOCUMENT PREPARED BY THE TRI-COUNCIL WORKING GROUP, Journal of psychiatry & neuroscience, 21(4), 1996, pp. 235-238
Authors:
PINARD L
NEGRETE JC
ANNABLE L
AUDET N
Citation: L. Pinard et al., ALEXITHYMIA IN SUBSTANCE-ABUSERS - PERSISTENCE AND CORRELATES OF VARIANCE, The American journal on addictions, 5(1), 1996, pp. 32-39
Authors:
SHRIQUI CL
ANNABLE L
DOUCET C
Citation: Cl. Shriqui et al., SCHIZOPHRENIC SYMPTOMS, TARDIVE-DYSKINESIA AND ITS ASSOCIATION WITH COGNITIVE-FUNCTIONING, Schizophrenia research, 18(2-3), 1996, p.
Authors:
GHADIRIAN AM
ANNABLE L
BELANGER MC
CHOUINARD G
Citation: Am. Ghadirian et al., A CROSS-SECTIONAL STUDY OF PARKINSONISM AND TARDIVE-DYSKINESIA IN LITHIUM-TREATED AFFECTIVE DISORDERED PATIENTS, The Journal of clinical psychiatry, 57(1), 1996, pp. 22-28
Authors:
SHRIQUI CL
ANNABLE L
BOUCHARD G
GRONDIN P
DUFOUR M
ROY M
Citation: Cl. Shriqui et al., TARDIVE-DYSKINESIA (TD) IN SCHIZOPHRENIC SUBJECTS - A CONTROLLED MAGNETIC-RESONANCE-IMAGING (MRI) STUDY, Schizophrenia research, 15(1-2), 1995, pp. 210-210
Authors:
SHRIQUI CL
ANNABLE L
Citation: Cl. Shriqui et L. Annable, TARDIVE-DYSKINESIA (TD) IN SCHIZOPHRENIC SUBJECTS - A CONTROLLED MAGNETIC-RESONANCE-IMAGING (MRI) STUDY, Schizophrenia research, 15(1-2), 1995, pp. 210-210
Authors:
KLINKE WP
BAIRD M
JUNEAU M
WATERS D
WARNICA W
LAKHANI Z
ANNABLE L
BOULET AP
LARIVIERE L
Citation: Wp. Klinke et al., ANTIANGINAL EFFICACY AND SAFETY OF CONTROLLED-DELIVERY DILTIAZEM QD VERSUS AN EQUIVALENT DOSE OF IMMEDIATE-RELEASE DILTIAZEM TID, Cardiovascular drugs and therapy, 9(2), 1995, pp. 319-330
Authors:
SELETTI B
BENKELFAT C
BLIER P
ANNABLE L
GILBERT F
DEMONTIGNY C
Citation: B. Seletti et al., SEROTONIN(1A) RECEPTOR ACTIVATION BY FLESINOXAN IN HUMANS - BODY-TEMPERATURE AND NEUROENDOCRINE RESPONSES, Neuropsychopharmacology, 13(2), 1995, pp. 93-104
Authors:
ANNABLE L
JONES B
NAIR V
REMINGTON G
WILLIAMS R
Citation: L. Annable et al., PSYCHOPHARMACOLOGY, Journal of psychiatry & neuroscience, 19(5), 1994, pp. 29-33
Authors:
STEINBERG S
ANNABLE L
YOUNG SN
BELANGER MC
Citation: S. Steinberg et al., TRYPTOPHAN IN THE TREATMENT OF LATE LUTEAL-PHASE DYSPHORIC DISORDER -A PILOT-STUDY, Journal of psychiatry & neuroscience, 19(2), 1994, pp. 114-119
Authors:
BEAUCLAIR L
FONTAINE R
ANNABLE L
HOLOBOW N
CHOUINARD G
Citation: L. Beauclair et al., CLONAZEPAM IN THE TREATMENT OF PANIC DISORDER - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL INVESTIGATING THE CORRELATION BETWEEN CLONAZEPAM CONCENTRATIONS IN PLASMA AND CLINICAL-RESPONSE, Journal of clinical psychopharmacology, 14(2), 1994, pp. 111-118
Authors:
BRADWEJN J
KOSZYCKI D
DUTERTRE AC
VANMEGEN H
DENBOER J
WESTENBERG H
ANNABLE L
Citation: J. Bradwejn et al., THE PANICOGENIC EFFECTS OF CHOLECYSTOKININ-TETRAPEPTIDE ARE ANTAGONIZED BY L-365,260, A CENTRAL CHOLECYSTOKININ RECEPTOR ANTAGONIST, IN PATIENTS WITH PANIC DISORDER, Archives of general psychiatry, 51(6), 1994, pp. 486-493
Authors:
CHOUINARD G
ANNABLE L
TURNIER L
HOLOBOW N
SZKRUMELAK N
Citation: G. Chouinard et al., A DOUBLE-BLIND RANDOMIZED CLINICAL-TRIAL OF RAPID TRANQUILIZATION WITH IM CLONAZEPAM AND IM HALOPERIDOL IN AGITATED PSYCHOTIC-PATIENTS WITHMANIC SYMPTOMS, Canadian journal of psychiatry, 38(9), 1993, pp. 190000114-190000121
Risultati:
1-15
|